![John Mulligan](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
John Mulligan
Oprichter bij
Good Therapeutics, Inc.
Profiel
John Mulligan is the founder and CEO of Good Therapeutics, Inc. which was founded in 2016.
He is also the founder of Bonum Therapeutics, Inc.
Actieve functies van John Mulligan
| Bedrijven | Functie | Begin |
|---|---|---|
Good Therapeutics, Inc.
 Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Oprichter | 01-01-2016 |
Bonum Therapeutics, Inc.
 Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
6
Eerstegraads connecties
2
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 2 |
|---|---|
Good Therapeutics, Inc.
Good Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops bio-therapeutics and self-regulating drugs | Health Technology |
Bonum Therapeutics, Inc.
Bonum Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Develops antibody-controlled cytokine based therapeutics designed to enhance the anti-tumor immune response | Commercial Services |
